Last updated at 04 May 2025 02:40 PM
Director
DIN: 10139229
Indeevarreddy Timmareddigarileela is currently associated with 2 companies in various capacities such as Director and Whole-time director. They serve as a Director at GAMAN PAIN CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10139229.Indeevarreddy Timmareddigarileela is currently involved in 2 different roles. Their most recent position is with GUTLIFE GASTRO CARE PRIVATE LIMITED as a Whole-time director. The first company Indeevarreddy Timmareddigarileela was appointed to as a director was GAMAN PAIN CARE PRIVATE LIMITED. Indeevarreddy Timmareddigarileela is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Indeevarreddy Timmareddigarileela is currently associated with 2 companies in various capacities such as Director and Whole-time director. They serve as a Director at GAMAN PAIN CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10139229.Indeevarreddy Timmareddigarileela is currently involved in 2 different roles. Their most recent position is with GUTLIFE GASTRO CARE PRIVATE LIMITED as a Whole-time director. The first company Indeevarreddy Timmareddigarileela was appointed to as a director was GAMAN PAIN CARE PRIVATE LIMITED. Indeevarreddy Timmareddigarileela is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
7 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GAMAN PAIN CARE PRIVATE LIMITED | Director | 28-Apr-2023 |
| GUTLIFE GASTRO CARE PRIVATE LIMITED | Whole-time director | 20-Feb-2024 |